Viewing Study NCT02949258

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:20 AM
Ignite Modification Date: 2026-03-07 @ 1:22 AM
Study NCT ID: NCT02949258
Status: UNKNOWN
Last Update Posted: 2016-10-31
First Post: 2016-10-27
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Neoadjuvant Chemotherapy With SEEOX Regimen for Borrmann Type 4 Gastric Cancer
Sponsor: Jinling Hospital, China
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Stomach Neoplasms View
None Gastric Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None gastric cancer View
None Borrmann type 4 View
None Neoadjuvant chemotherapy View
None Intra-arterial administration View